Sana Biotechnology, Inc.
SANA
$3.58
-$0.02-0.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -89.92% | -0.65% | 18.11% | -19.15% | 53.21% |
| Total Depreciation and Amortization | -21.70% | -4.02% | -6.29% | 4.16% | 3.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 670.80% | 228.81% | -240.37% | 130.30% | -131.81% |
| Change in Net Operating Assets | 68.99% | -354.23% | 1,341.57% | -114.64% | 131.48% |
| Cash from Operations | 31.97% | -3.17% | 8.99% | 11.48% | 10.80% |
| Capital Expenditure | 182.35% | 68.81% | 89.35% | 68.65% | 17.60% |
| Sale of Property, Plant, and Equipment | 50.99% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.41% | -65.31% | 3.61% | 143.02% | 130.75% |
| Cash from Investing | -53.74% | -64.74% | 12.72% | 618.03% | 107.53% |
| Total Debt Issued | -- | -- | -132.56% | -97.75% | -- |
| Total Debt Repaid | -1.18% | -- | -- | -- | -- |
| Issuance of Common Stock | -47.91% | 61.23% | -63.40% | -36.31% | -98.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | -42.87% | 52.72% | -69.12% | -80.41% | -94.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.99% | -5,551.23% | 107.16% | 81.09% | -196.69% |